The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
NHC · Healthcare · Narrow moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
MDNC · Healthcare · Narrow moat
On the watchlist
The businessTrend component abstained: Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend. The other four 20% weights were renormalized over the scored 80%.
BBNX · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | NHC | ABBV | MDNC | BBNX |
|---|---|---|---|---|
| Moat Score (0–100) | 65 (highest) | 65 (highest) | 65 (highest) | 65 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 87 (highest) | 70 | — | 60 |
| Pricing power | — | 95 (highest) | 84 | 92 |
| Returns on capital | 3 | 97 | 100 (highest) | — |
| Balance-sheet safety | 100 (highest) | 26 | 54 | 55 |
| Capital discipline | 71 (highest) | 38 | 24 | 54 |
| Price vs. high estimate | 63% above high estimate (largest discount to high estimate) | 215% above high estimate | No price data | No price data |
| Market cap | $3.4B | $448.0B | — | $790.5M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filings as of | FY2025 | FY2025 | FY2026 | FY2025 |